Director dealings: Genedrive CEO raises stake
By Iain Gilbert
Date: Tuesday 01 Sep 2026
(Sharecast News) - Genedrive revealed on Tuesday that chief executive Gino Miele had acquired 700,000 ordinary shares in the AIM-listed pharmacogenetic testing company.
Miele, who took over as CEO in August 2024, purchased the shares at an average price of 1.38p each, for a total value of £9,660.
Following the purchase, Miele holds a beneficial interest in 7.9m ordinary Genedrive shares, representing approximately 0.49% of the company's issued share capital.
As of 1415 BST, Genedrive shares were up 7.14% at 1.50p.
Reporting by Iain Gilbert at Sharecast.com
Top Director Buys
Staffline Group (STAF)
Director name: Spain,Thomas
Amount purchased: 75,249 @ 42.00p
Value: £31,604.58
Genedrive (GDR)
Director name: Miele,Gino
Amount purchased: 700,000 @ 1.38p
Value: £9,660.00
Invesco Bond Income Plus Limited Npv (BIPS)
Director name: Kumar ,Arun
Amount purchased: 2,757 @ 170.74p
Value: £4,707.30
Top Director Sells
Staffline Group (STAF)
Director name: Spain,Thomas
Amount sold: 75,249 @ 42.00p
Value: £31,604.58
Email this article to a friend
or share it with one of these popular networks:
You are here: news
10 Lower Thames St,
London EC3R 6EN